KQ · Healthcare

EuBiologics Co. Ltd. (206650)

Drug Manufacturers - Specialty & Generic

EuBiologics Co. Ltd. (206650) is listed on KQ in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 206650

P/E ratio

18.00

EuBiologics Co. Ltd. (206650) — FAQ

What is 206650's P/E ratio?

The price-to-earnings (P/E) ratio for EuBiologics Co. Ltd. (206650) is 18.00 (data as of 2026-05-24).

Does EuBiologics Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for EuBiologics Co. Ltd. (206650). Check the MyAverix Finance app for the latest dividend data.

What sector is EuBiologics Co. Ltd. in?

EuBiologics Co. Ltd. (206650) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 206650 listed on?

206650 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)